A novel SPE-UPLC-MS/MS-based assay for the selective, simultaneous quantification of xylosyltransferase-I and -II activity
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved..
Xylosyltransferase-I and -II (XT-I, -II) possess a central role during the glycosylation of proteoglycans (PGs). They catalyze the formation of an O-glycosidic bond between the xylosyl residue of uridinediphosphate-xylose and the core protein of a PG. Thereafter, three following glycosyltransferases lead to the generation of a tetrasaccharide linker, which connects the PG core protein to the respective glycosaminoglycan. The selective quantification of XT-I and XT-II activity is of biological and clinical interest due to their association with fibrotic processes and skeletal dysplasia. There is no assay available to date that simultaneously determines the activity of the two XT isoforms. Although an XT-I selective UPLC MS/MS-based assay was published by Fischer et al., in 2021, the determination of XT-II activity can only be performed simultaneously by the improved assay presented here. To establish the assay, two synthetic peptides, selectively xylosylated by the respective isoform, were identified and the associated measurement parameters for the mass spectrometer were optimized. In addition, the quantitative range of the xylosylated peptides were validated, and the incubation time of the enzyme reaction was optimized for cell culture samples and human sera. The specific enzyme kinetics (KM and Vmax) of the respective XT isoform for the two peptides were also determined. Subsequently, a mathematical model was developed, allowing the simultaneous determination of XT-I and XT-II activity from the chromatographic results. Summarized, a mass spectrometric method suitable for the simultaneous analysis of XT-I and XT-II activity in cell culture lysates, supernatants and human sera was successfully developed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:218 |
---|---|
Enthalten in: |
Biochimie - 218(2024) vom: 23. Feb., Seite 127-136 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kleine, Anika [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 21.02.2024 Date Revised 21.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.biochi.2023.09.008 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361867433 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM361867433 | ||
003 | DE-627 | ||
005 | 20240222091342.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.biochi.2023.09.008 |2 doi | |
028 | 5 | 2 | |a pubmed24n1301.xml |
035 | |a (DE-627)NLM361867433 | ||
035 | |a (NLM)37689257 | ||
035 | |a (PII)S0300-9084(23)00217-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kleine, Anika |e verfasserin |4 aut | |
245 | 1 | 2 | |a A novel SPE-UPLC-MS/MS-based assay for the selective, simultaneous quantification of xylosyltransferase-I and -II activity |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.02.2024 | ||
500 | |a Date Revised 21.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved. | ||
520 | |a Xylosyltransferase-I and -II (XT-I, -II) possess a central role during the glycosylation of proteoglycans (PGs). They catalyze the formation of an O-glycosidic bond between the xylosyl residue of uridinediphosphate-xylose and the core protein of a PG. Thereafter, three following glycosyltransferases lead to the generation of a tetrasaccharide linker, which connects the PG core protein to the respective glycosaminoglycan. The selective quantification of XT-I and XT-II activity is of biological and clinical interest due to their association with fibrotic processes and skeletal dysplasia. There is no assay available to date that simultaneously determines the activity of the two XT isoforms. Although an XT-I selective UPLC MS/MS-based assay was published by Fischer et al., in 2021, the determination of XT-II activity can only be performed simultaneously by the improved assay presented here. To establish the assay, two synthetic peptides, selectively xylosylated by the respective isoform, were identified and the associated measurement parameters for the mass spectrometer were optimized. In addition, the quantitative range of the xylosylated peptides were validated, and the incubation time of the enzyme reaction was optimized for cell culture samples and human sera. The specific enzyme kinetics (KM and Vmax) of the respective XT isoform for the two peptides were also determined. Subsequently, a mathematical model was developed, allowing the simultaneous determination of XT-I and XT-II activity from the chromatographic results. Summarized, a mass spectrometric method suitable for the simultaneous analysis of XT-I and XT-II activity in cell culture lysates, supernatants and human sera was successfully developed | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Extracellular matrix | |
650 | 4 | |a Fibrosis | |
650 | 4 | |a Glycosaminoglycan | |
650 | 4 | |a Human xylosyltransferase-I and -II | |
650 | 4 | |a Mass spectrometry | |
650 | 4 | |a Proteoglycan synthesis | |
650 | 7 | |a UDP Xylose-Protein Xylosyltransferase |2 NLM | |
650 | 7 | |a EC 2.4.2.26 |2 NLM | |
650 | 7 | |a Pentosyltransferases |2 NLM | |
650 | 7 | |a EC 2.4.2.- |2 NLM | |
650 | 7 | |a Protein Isoforms |2 NLM | |
650 | 7 | |a Peptides |2 NLM | |
700 | 1 | |a Kühle, Matthias |e verfasserin |4 aut | |
700 | 1 | |a Kuhn, Joachim |e verfasserin |4 aut | |
700 | 1 | |a Ly, Thanh-Diep |e verfasserin |4 aut | |
700 | 1 | |a Schmidt, Vanessa |e verfasserin |4 aut | |
700 | 1 | |a Faust-Hinse, Isabel |e verfasserin |4 aut | |
700 | 1 | |a Knabbe, Cornelius |e verfasserin |4 aut | |
700 | 1 | |a Fischer, Bastian |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biochimie |d 1971 |g 218(2024) vom: 23. Feb., Seite 127-136 |w (DE-627)NLM000014419 |x 1638-6183 |7 nnns |
773 | 1 | 8 | |g volume:218 |g year:2024 |g day:23 |g month:02 |g pages:127-136 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.biochi.2023.09.008 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 218 |j 2024 |b 23 |c 02 |h 127-136 |